Showing results (411-420 of 604) with videos related to

Sort By:
Pageof 61
Diagnostics (Basel, Switzerland)|July 2, 2021
Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic SclerosisAudrey Benyamine, Daniel Bertin, Noémie Resseguier, et al.
RMD Open|November 8, 2018
Relapsing polychondritis: state of the art on clinical practice guidelinesSimona Rednic, Laura Damian, Rosaria Talarico, et al.
Rheumatology (Oxford, England)|December 7, 2013
Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysisAndrea D Keck, Chingching Foocharoen, Edoardo Rosato, et al.
Intensive Care Medicine|October 22, 2025
Life-threatening immune-related adverse events in the intensive care unit: a narrative reviewSamuel Pichon, Ghadi Zebian, Côme Bureau, et al.
Annals of the Rheumatic Diseases|October 25, 2014
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective studyMuriel Elhai, Jérôme Avouac, Ulrich A Walker, et al.
The European Respiratory Journal|October 21, 2017
Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosisBruno Degano, Thibaud Soumagne, Thomas Delaye, et al.
Medicine|May 22, 2015
In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndromeAlain Meyer, Guillaume Lefevre, Guillaume Bierry, et al.
Journal of Clinical Immunology|May 4, 2010
B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the diseaseGaël Mouillot, Maryvonnick Carmagnat, Laurence Gérard, et al.
The Lancet. Rheumatology|March 31, 2021
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort studyJérôme Avouac, Elodie Drumez, Eric Hachulla, et al.
The Lancet. Rheumatology|January 24, 2024
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohortMuriel Elhai, Nanthara Sritharan, Marouane Boubaya, et al.
Pageof 61